What's newtag icon
Our latest AI innovations will deliver tomorrow's market todayDiscover howbanner icon
Bioatla

November 2025

Bioatla Market Share Analysis for November 2025

Revolutionizing cancer therapy with Conditionally Active Biologics™
Year Founded2007
Employees51 - 200
Annual Revenue$10M - $15M
bioatla.com
Bioatla
Bioatla (including company regionals)
  • bioatla.com
    bioatla.com
See more website traffic and engagement information

Bioatla Revenue up to November 2025 is 10M - 15M

revenue generated by Bioatla top domains

Bioatla top domains revenue over 3 years

Revenue for Bioatla top domains


Total visits to Bioatla's top domains

Understand Bioatla market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Bioatla's top domains

Analyze Bioatla engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Bioatla's top domains

See how Bioatla keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Bioatla

These are the website technologies, by industry, used by Bioatla top domains

Widget (7)

reCAPTCHA

reCAPTCHA

Conversion & Analytics (2)

Google Analytics

Google Analytics

Marketing (2)

Google Marketing Platform

Google Marketing Platform

Mobile (2)

Meta Viewport

Meta Viewport

More Technologies

7

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Bioatla

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBioAtla LLC attends event SITC 2025.BioAtla to present clinical data for mecbotamab vedotin (BA3011) in soft tissue sarcoma at SITC 2025.
NewsBioAtla LLC attends event ESMO 2025.BioAtla has shared ongoing P-I dose-escalation trial data on BA3182 for treatment-refractory metastatic adenocarcinoma at ESMO 2025
NewsBioAtla LLC attends event 2025 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress.BioAtla presents data from ongoing dose escalation of BA3182, Dual-Conditionally Binding EpCAM x CD3 Bispecific T-cell Engager, in Patients with Treatment Refractory Metastatic Adenocarcinoma at the 2025 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress.

See all Bioatla signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.